Infliximab-associated lymphoproliferative disorders

被引:6
作者
Hoshida, Y
Yamamoto, S
Wada, N
Xu, JX
Sasaki, T
Aozasa, K
机构
[1] Osaka Univ, Grad Sch Med, Dept Pathol, Suita, Osaka 5650871, Japan
[2] Sakai Municipal Hosp, Dept Pathol, Osaka, Japan
关键词
D O I
10.1532/IJH97.05026
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:356 / 357
页数:2
相关论文
共 9 条
[1]   Rheumatoid arthritis and malignant lymphomas [J].
Baecklund, E ;
Askling, J ;
Rosenquist, R ;
Ekbom, A ;
Klareskog, L .
CURRENT OPINION IN RHEUMATOLOGY, 2004, 16 (03) :254-261
[2]   Tumor necrosis factor antagonist therapy and lymphoma development - Twenty-six cases reported to the Food and Drug Administration [J].
Brown, SL ;
Greene, MH ;
Gershon, SK ;
Edwards, ET ;
Braun, MM .
ARTHRITIS AND RHEUMATISM, 2002, 46 (12) :3151-3158
[3]   INCIDENCE OF CANCER AMONG PATIENTS WITH RHEUMATOID-ARTHRITIS [J].
GRIDLEY, G ;
MCLAUGHLIN, JK ;
EKBOM, A ;
KLARESKOG, L ;
ADAMI, HO ;
HACKER, DG ;
HOOVER, R ;
FRAUMENI, JF .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (04) :307-311
[4]  
Harris N., 2001, PATHOLOGY GENETICS T, P270
[5]   Rheumatoid arthritis and cancer risk [J].
Mellemkjaer, L ;
Linet, MS ;
Gridley, G ;
Frisch, M ;
Moller, H ;
Olsen, JH .
EUROPEAN JOURNAL OF CANCER, 1996, 32A (10) :1753-1757
[6]   Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases [J].
Salloum, E ;
Cooper, DL ;
Howe, G ;
Lacy, J ;
Tallini, G ;
Crouch, J ;
Schultz, M ;
Murren, J .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (06) :1943-1949
[7]  
Thomas E, 2000, INT J CANCER, V88, P497, DOI 10.1002/1097-0215(20001101)88:3<497::AID-IJC27>3.3.CO
[8]  
2-A
[9]   Lymphoma in rheumatoid arthritis - The effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients [J].
Wolfe, F ;
Michaud, K .
ARTHRITIS AND RHEUMATISM, 2004, 50 (06) :1740-1751